Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Minerva Neurosciences (NERV) Non-cash Items (2016 - 2026)

Minerva Neurosciences filings provide 3 years of Non-cash Items readings, the most recent being $913530.0 for Q3 2021.

  • On a quarterly basis, Non-cash Items fell 83.52% to $913530.0 in Q3 2021 year-over-year; TTM through Sep 2021 was $913530.0, a 83.52% decrease, with the full-year FY2019 number at $7.4 million, changed N/A from a year prior.
  • Non-cash Items hit $913530.0 in Q3 2021 for Minerva Neurosciences, down from $6.9 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $7.4 million in Q4 2019 to a low of $29000.0 in Q2 2020.
  • Median Non-cash Items over the past 3 years was $5.6 million (2020), compared with a mean of $4.7 million.
  • The widest YoY moves for Non-cash Items: up 23843.69% in 2021, down 83.52% in 2021.
  • Minerva Neurosciences' Non-cash Items stood at $7.4 million in 2019, then fell by 25.29% to $5.5 million in 2020, then plummeted by 83.52% to $913530.0 in 2021.
  • The last three reported values for Non-cash Items were $913530.0 (Q3 2021), $6.9 million (Q2 2021), and $6.6 million (Q1 2021) per Business Quant data.